lifestyle.thedishh.com

Author: Knight Therapeutics

Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results

March 19, 2026
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil

February 18, 2026